Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Apr 11, 2022 · 10-K · 101 days after period end · 0001539497-22-000793
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2017 |
|---|---|---|---|---|
| Revenue | — | — | — | $32.19K |
| Net Income | -$998.40K | -$871.39K | -$662.66K | -$86.41K |
| EPS Diluted | — | — | — |
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Apr 11, 2022 · 101 d after period end
